Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients
Completed · Phase 4
Conditions studied: HIV, Combination Therapy
In brief
The purpose of this study is to determine whether HIV-1-infected patients, who are virologically suppressed on a regimen of 2 nucleoside reverse transcriptase inhibitors plus any third agent but are experiencing safety and/or tolerability issues, will maintain virologic suppression after switching to a regimen of heat-stable ritonavir boosted atazanavir, 300/100 mg, once daily plus raltegravir, 400 mg, twice daily.
Key facts
- Study ID
- NCT01332227
- Run by
- Bristol-Myers Squibb
- People needed
- 132
- Starts
- 2011-10-01
- Expected to finish
- 2014-02-01
- Last updated by the study team
- 2015-02-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Health For Life Clinic Pllc — Little Rock, Arkansas, United States
- Eisenhower Medical Center — Palm Springs, California, United States
- Metropolis Medical Pc — San Francisco, California, United States
- Consultive Medicine — Daytona Beach, Florida, United States
- Orange County Health Dept. — Orlando, Florida, United States
- Triple O Medical Services, P.A. — West Palm Beach, Florida, United States
- The Research Institute — Springfield, Massachusetts, United States
- Aids Care — Rochester, New York, United States
- Local Institution — Paris, Cedex 12, France
- Local Institution — Lyon, France
- Local Institution — Orléans, France
- Local Institution — Paris, France
- Local Institution — Paris, France
- Local Institution — Strasbourg, France
- Local Institution — Bochum, Germany
- Local Institution — Frankfurt, Germany
- Local Institution — Frankfurt am Main, Germany
- Local Institution — Hamburg, Germany
- Local Institution — Munich, Germany
- Local Institution — Genova, Italy
- Local Institution — Genova, Italy
- Local Institution — Milan, Italy
- Local Institution — Milan, Italy
- Local Institution — Roma, Italy
- Local Institution — Warsaw, Poland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.